CompletedNCT01965704
Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent Women
Medication studyUp to age 45United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: up to 45 years.
- Listed locations
- San Francisco and 7 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: September 9, 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 196
- Sponsor
- Stanford University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Up to 45 Years
- Official registry ID
- NCT01965704
- Official title
Show the full official title
AIM 2- Prevention of Neonatal Abstinence Syndrome
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
San Francisco · San Jose · Stanford
5 more locations
- Louisville
- Baltimore
- Philadelphia
- Memphis
- Salt Lake City
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Stanford University, a university.
Did this study involve medication?
Yes. The study involved medication, including Ondansetron and Placebo.
Who was this study for?
Listed age limits: up to 45 years.
